Seriously Undervalued..OCLG..Acquiring company generating $9.8 million in revenues!!!.. OCLG added an additional acquisition candidate to their Home Medical/Durable Medical Equipment (DME) division who is located in the same geographic market as our initial target... makes it 2 Acquisitions...These combined acquisition targets will potentially increase OCLG's total annualized revenues by $19.5 million and annualized EBITDA by $3.3 million..!...
OCLG..2015 year-end objective of $35 million in top-line revenues with positive EBITDA exceeding $4.0 million. With the execution of these acquisitions, debt reduction and growth plans, we are confident that our stock value will rise well beyond its current enterprise value of $3.82 million..
From the news today OCLG the Company has repaid over $1,470,000 of corporate debt
OCLG Subsidiary Dotolo is a FDA Registered, Class II, medical device manufacturer in the hydro-colonic irrigation and bowel preparation market..This is BIG..
News 
Market Data 
Discover 
AI
